Germany's Merck KGaA raised its full-year guidance for growth in underlying earnings, thanks to better prospects for its life-sciences and healthcare segments, but turned more cautious on sales.

Germany's Merck KGaA on Thursday raised its full-year operating earnings guidance, excluding the effect of harsh foreign ...

The highest-paying dividend stocks in the Dow Jones Industrial Average right now are Verizon Communications (NYSE: VZ), ...

The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...

Merck KGaA closed the divestment of its global Surface Solutions business to Global New Material International Holdings Ltd. ...

MRK scores an A+ grade for Profitability, aided by high gross and EBITDA margins of 78% and 46%, respectively. Moreover, it ...

Gemini Insurance is under fire after a $2.5 million settlement claim, with Merck and Jones Lang LaSalle demanding coverage ...

Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and ...

AI cloud firm CoreWeave is buying an entire tech and life science campus where it previously leased a single data center.

Merck & Co., Inc. (NYSE:MRK) is one of the top cheap pharmaceutical stocks to buy now. Goldman Sachs analyst Asad Haider ...

President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...